|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.30 EUR | -1.89% |
|
+0.25% | +15.27% |
| 07-11 | BIOMERIEUX : Attractiveness reinforced |  |
| 06-16 | BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc. | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility (Composite) | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 13 | ||||||||
| 22 | ||||||||
| 10 | ||||||||
| 12 | ||||||||
| 13 | ||||||||
| 4 | ||||||||
| - | - | - | - | |||||
| 4 | ||||||||
| - | - | |||||||
| 2 | ||||||||
| 13 | ||||||||
| - | 1 | |||||||
| 3 | ||||||||
| 4 | ||||||||
| - | - | |||||||
| 1 | ||||||||
| - | 1 | |||||||
| 2 | ||||||||
| Average | 7 | |||||||
| Weighted average by Cap. | 11 |
- Stock Market
- Equities
- BIM Stock
- Sector bioMérieux
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition